Rabavert rabies vacc w-diluents
Ended Awarded
- Contract number
- SPE2DB25FBNQT
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,351
Award facts
- Contract value 100% obligated
- $1,350.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,350.60 to DMS Pharmaceutical Group Inc. for Rabavert rabies vaccine with diluents. The contract, issued on September 10, 2025, with an ultimate completion date of September 11, 2025, carries a firm fixed-price structure with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform the work at its Park Ridge facility. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that authorizes the issuance of firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing contracts to deliver branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to Department of Defense healthcare sites. The company's federal contract portfolio encompasses an extensive array of medical products, from specialty pharmaceuticals to vaccines and injections. This delivery order for rabies vaccine represents a routine procurement under the company's established relationship with the DLA, demonstrating its operational capacity to fulfill urgent medical supply needs for military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FBNQT?
SPE2DB25FBNQT was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FBNQT worth?
The government has obligated $1,351 on SPE2DB25FBNQT.
Is contract SPE2DB25FBNQT an order under another contract?
Yes. SPE2DB25FBNQT is a delivery order under SPE2DB24D9211, an indefinite delivery contract.
Was contract SPE2DB25FBNQT competed?
The extent of competition for SPE2DB25FBNQT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award